Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Rhea-AI Summary

Novavax (Nasdaq: NVAX) will report its third quarter 2025 financial results and operational highlights on November 6, 2025 at 8:30 a.m. ET.

Investors can join the live conference call by registering for an automated callback or dialing the listed numbers. A live webcast and replay will be available at ir.novavax.com/events. The teleconference replay is available from 11:30 a.m. ET on November 6, 2025 until 11:59 p.m. ET on November 13, 2025, and the webcast replay will remain on the investor site until December 5, 2025.

GAITHERSBURG, Md., Oct. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, November 6, 2025. Details of the event and replay are as follows:

Conference call details:
Date:	November 6, 2025
Time:	8:30 a.m. ET
URL to register phone:	Register Here
Dial-in number:	(888) 880-3330 (U.S.) or
	(+1) (646) 357-8766 (International)
Webcast:	ir.novavax.com/events

• Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
• Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
• To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.

Replay details:
Date:	Available starting at 11:30 a.m. ET, November 6, 2025, until 11:59 p.m. ET, November 13, 2025
Dial-in number:	(800) 770-2030 (U.S.) or
	(+1) (609) 800-9909 (International)
Passcode:	3585070#
Webcast:	ir.novavax.com/events, until December 5, 2025

About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M^® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.

Contacts: 

Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com

Media
Yvonne Sprow
844-264-8571
media@novavax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-third-quarter-2025-financial-results-on-november-6-2025-302599179.html

SOURCE Novavax, Inc.

FAQ

When will Novavax (NVAX) report third quarter 2025 results?

Novavax will report Q3 2025 results on November 6, 2025 at 8:30 a.m. ET.

How can investors join the Novavax (NVAX) Q3 2025 earnings call on November 6, 2025?

Investors can register for an automated callback via the registration URL or dial the listed U.S. or international conference numbers to join.

Where is the Novavax (NVAX) webcast for the November 6, 2025 call available?

The live webcast and replay are available at ir.novavax.com/events.

When is the teleconference replay for Novavax (NVAX) Q3 2025 available?

The teleconference replay is available from 11:30 a.m. ET on November 6, 2025 until 11:59 p.m. ET on November 13, 2025.

What are the Novavax (NVAX) conference call dial-in numbers for the November 6, 2025 event?

U.S. dial-in: (888) 880-3330; International: +1 (646) 357-8766. Replay numbers are also provided on the investor site.